Observan un marcado aumento en los niveles de contaminación atmosférica en los últimos años
JUEVES, 21 de abril de 2022 (HealthDay News) — Tras 23 años de reducciones en los niveles generales de contaminación atmosférica, un nuevo informe muestra que Estados Unidos registró el número más alto de toda la historia de días con un aire de calid…
Learn More¿Es el ayuno intermitente mejor que las dietas típicas para perder peso?
JUEVES, 21 de abril de 2022 (HealthDay News) — La alimentación en “horario restringido” se ha convertido en una popular táctica para perder peso, pero un nuevo ensayo clínico no encuentra ningún beneficio cuando se añade a la reducción de calorías tr…
Learn MoreLos exjugadores de fútbol americano universitario sufren más trastornos cerebrales al envejecer
JUEVES, 21 de abril de 2022 (HealthDay News) — Los jugadores de fútbol americano universitario viven más tiempo que los que no jugaban, pero sufren más problemas relacionados con el cerebro al envejecer, encuentra un nuevo estudio.Entre los exjugador…
Learn MorePhiladelphia Lifts Indoor Mask Mandate Enacted 4 Days Ago
FRIDAY, April 22, 2022 (HealthDay News) — The indoor mask mandate that was reinstated in Philadelphia on Monday due to rising coronavirus cases has now been lifted because the situation is improving, the city’s health department said Thursday.The cit…
Learn MoreAHA News: Confused About COVID-19 Boosters? Experts Answer 6 Common Questions
FRIDAY, April 22, 2022 (American Heart Association News) — When the Food and Drug Administration recently authorized a second COVID-19 booster shot for some people, many of those eligible wondered whether to get one – and when, given that cases are o…
Learn MoreAHA News: Air Pollution Exposure May Cause Heart Attack Within an Hour
FRIDAY, April 22, 2022 (American Heart Association News) — Exposure to air pollutants – even at levels below World Health Organization air quality guidelines – may trigger a heart attack within the hour, according to a new study from China that found…
Learn MoreSingle Dose of AZD7442 Prevents Symptomatic or Severe COVID-19
FRIDAY, April 22, 2022 (HealthDay News) — A single dose of the monoclonal antibody combination AZD7442 (tixagevimab and cilgavimab) is effective for preventing symptomatic or severe COVID-19 in adults, according to a study published online April 20 i…
Learn MoreAdding Tislelizumab to Chemo Slows Advanced Nasopharyngeal Cancer
FRIDAY, April 22, 2022 (HealthDay News) — The addition of tislelizumab to chemotherapy improves progression-free survival (PFS) in recurrent/metastatic nasopharyngeal cancer (RM NPC), according to a study presented April 18 as part of the American So…
Learn MoreWearables Detect Physiologic Changes at COVID-19 Symptom Onset
FRIDAY, April 22, 2022 (HealthDay News) — There are alterations in physiologically based parameters of heart rate around the time of COVID-19 symptom onset, which can differentiate symptomatic and healthy periods, according to a study published in th…
Learn MoreGuideline Issued for Preventing SSI After Major Extremity Trauma
FRIDAY, April 22, 2022 (HealthDay News) — In an evidence-based clinical practice guideline published by the American Academy of Orthopaedic Surgeons, recommendations are presented for the prevention of surgical site infection (SSI) after major extrem…
Learn More